Helix3

Helix3 Inc. is a private, revenue-generating contract research laboratory headquartered in San Francisco, operating in the drug discovery services sector. The company's core business is providing GLP-compliant contract research services, including study design, method development, and in vitro/in vivo testing to support client regulatory submissions. While its founding date is 2017, its team has a proven, long-term track record working together since 1994, suggesting deep experience and stability. Helix3 differentiates itself by offering a blend of academic-style flexibility and innovation with the rigorous quality standards of a GLP laboratory.

Experienced team providing GLP-compliant method development and customized in vitro/in vivo study services. No proprietary AI platform indicated.

Helix3 competes in the fragmented contract research organization market. It faces competition from large, full-service global CROs (e.g., Charles River, LabCorp) and numerous small, specialized labs. Its differentiation is based on team longevity, flexibility, and a focus on method development within a GLP framework, rather than scale or proprietary technology.